San Luis Wealth Advisors LLC Has $589,000 Holdings in Kenvue Inc. $KVUE

San Luis Wealth Advisors LLC lifted its position in shares of Kenvue Inc. (NYSE:KVUE) by 19.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,161 shares of the company’s stock after buying an additional 4,526 shares during the period. San Luis Wealth Advisors LLC’s holdings in Kenvue were worth $589,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the company. Cambridge Investment Research Advisors Inc. boosted its stake in Kenvue by 4.0% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 106,140 shares of the company’s stock valued at $2,545,000 after purchasing an additional 4,034 shares during the last quarter. Arlington Partners LLC acquired a new position in Kenvue in the 2nd quarter valued at $2,110,000. Farther Finance Advisors LLC increased its position in Kenvue by 80.7% during the 2nd quarter. Farther Finance Advisors LLC now owns 36,196 shares of the company’s stock worth $758,000 after purchasing an additional 16,164 shares in the last quarter. IFP Advisors Inc lifted its stake in Kenvue by 25.3% during the first quarter. IFP Advisors Inc now owns 15,278 shares of the company’s stock worth $369,000 after purchasing an additional 3,081 shares during the last quarter. Finally, Vident Advisory LLC purchased a new position in Kenvue in the 1st quarter worth about $520,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. Bank of America decreased their target price on Kenvue from $27.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday, July 15th. Royal Bank Of Canada decreased their target price on Kenvue from $24.00 to $22.00 and set a “sector perform” rating for the company in a research report on Friday, August 8th. JPMorgan Chase & Co. cut their price objective on Kenvue from $27.00 to $26.00 and set an “overweight” rating for the company in a research report on Friday, July 25th. Rothschild Redb raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday. Finally, Evercore ISI reduced their price target on shares of Kenvue from $23.00 to $18.00 and set an “in-line” rating for the company in a research report on Tuesday, September 23rd. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $23.12.

Kenvue Stock Up 1.4%

Shares of NYSE KVUE opened at $16.40 on Friday. Kenvue Inc. has a 1 year low of $16.07 and a 1 year high of $25.17. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The firm’s 50-day moving average is $20.37 and its 200-day moving average is $21.82. The firm has a market capitalization of $31.48 billion, a PE ratio of 22.17, a price-to-earnings-growth ratio of 2.36 and a beta of 0.83.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.01. The company had revenue of $3.84 billion for the quarter, compared to analyst estimates of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.Kenvue’s revenue for the quarter was down 4.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were paid a dividend of $0.2075 per share. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.1%. Kenvue’s dividend payout ratio is 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.